Developing an AI Pharmacy Chatbot for the Population of Hong Kong

NARecruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
HyperglycaemiaHypertensionHyperlipidaemiaArtificial Intelligence (AI)
Interventions
OTHER

An AI pharmacy chatbot offering information related to HA-prescribed medication for hyperglycaemia, hypertension, and hyperlipidaemia

It is a chatbot for HA-prescribed medication used for treating hyperglycaemia, hypertension, and hyperlipidaemia, available through WhatsApp. All the responses will be extracted from a database, in which the content was obtained from and validated by pharmacists from the Chief Pharmacist's Office of the Hospital Authority in Hong Kong. The intervention period will last for 7 days.

Trial Locations (2)

Unknown

RECRUITING

Laboratory of Data Discovery for Health, Hong Kong

RECRUITING

The University of Hong Kong, Hong Kong

All Listed Sponsors
collaborator

Laboratory of Data Discovery for Health

UNKNOWN

collaborator

Hospital Authority, Hong Kong

OTHER_GOV

lead

The University of Hong Kong

OTHER

NCT07037563 - Developing an AI Pharmacy Chatbot for the Population of Hong Kong | Biotech Hunter | Biotech Hunter